COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,844 Articles (22,553 medRxiv, 8,291 bioRxiv)

Most recent first Previous |  Page 469: Articles 4681-4690  | Next

Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: cohort study
Chang, Y.-S., Huang, K., Lee, J. M., Vagts, C. L., Ascoli, C., Amin, M.-R., Ghassemi, M., Lora, C. M., Edafetanure-Ibeh, R., Huang, Y., Cherian, R. A., Sarup, N., Warpecha, S. R., Hwang, S., Goel, R., Turturice, B. A., Schott, C., Hernandez, M., Chen, Y., Jorgensen, J., Wang, W., Rasic, M., Novak, R. M., Perkins, D. L., Finn, P. W.
10.1101/2023.01.19.23284792 — Posted: 2023-01-19
Raman spectroscopy, used trans-cutaneously and non-invasively from a finger, to predict COVID-19: A feasibility, proof-of-concept study.
Chefitz, A. B., Birch, T., Yang, Y., Hussain, A.
10.1101/2023.01.19.23284747 — Posted: 2023-01-19
Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection
Antar, A. A. R., Yu, T., Demko, Z. O., Hu, C., Tornheim, J. A., Blair, P. W., Thomas, D. L., Manabe, Y. C., OutSMART Study Group
10.1101/2023.01.18.23284742 — Posted: 2023-01-19
A computable phenotype for patients with SARS-CoV2 testing that occurred outside the hospital
Wang, L., Zipursky, A., Geva, A., McMurry, A., Mandl, K. D., Miller, T. A.
10.1101/2023.01.19.23284738 — Posted: 2023-01-19
Ensemble of deep learning language models to support the creation of living systematic reviews for the COVID-19 literature: a retrospective study
Knafou, J., Haas, Q., Borissov, N., Counotte, M. J., Low, N., Imeri, H., Ipekci, A. M., Buitrago-Garcia, D., Heron, L., Amini, P., Teodoro, D.
10.1101/2023.01.18.524571 — Posted: 2023-01-19
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate
Moros, A., Prefaneta, A., Barreiro, A., Perozo, E., Fernandez, A., Canete, M., Gonzalez, L., Garriga, C., Pradenas, E., Marfil, S., Blanco, J., Cebollada-Rica, P., Sistere-Oro, M., Meyerhans, A., Prat Cabanas, T., March, R., Ferrer, L.
10.1101/2023.01.19.524684 — Posted: 2023-01-19
Comparative effectiveness of the bivalent BA.4-5 and BA.1 mRNA-booster vaccines in the Nordic countries
Andersson, N. W., Thiesson, E. M., Baum, U., Pihlstrom, N., Starrfelt, J., Faksova, K., Poukka, E., Meijerink, H., Ljung, R., Hviid, A.
10.1101/2023.01.19.23284764 — Posted: 2023-01-19
Determining latent features and forecasting of COVID-19 hospitalisations in Malaysia using a national patient assessment data platform: a study of machine learning modelling against expert system
Yee, H. J., Boo, I., Tan, I. K. T., Tan, J. S., Zakariah, H.
10.1101/2023.01.17.22281858 — Posted: 2023-01-18
Assessment of Willingness to Receive COVID-19 Vaccine and Associated Factors among Teachers in Dambi Dollo Town, Qellem Wallaga Zone, Oromia Regional State, Ethiopia: Institution based cross sectional study
Mengesha, d. S., Melaku, C., Ayana, L. A., Benti, T. K.
10.1101/2023.01.17.23284660 — Posted: 2023-01-18
Mixed Attention with Deep Supervision for Delineation of COVID Infection in Lung CT
Dutta, P., Mitra, S.
10.1101/2023.01.17.23284673 — Posted: 2023-01-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).